For biotech to achieve our societal goals, we need to build up the foundational systems that support modern science. Government investment will be critical. Technological resources will also be instrumental — from overcoming current technical skills gaps to modernising how we move novel cell and gene therapies from R&D and intro production, to ensuring scientists are set-up for success with AI for drug discovery. I come at this from the perspective of a technologist working in the biotech sector, and the trends that I’m focused on are about applying the tech industry’s knack for innovation to the biotech industry’s greatest bottlenecks and foundational systems’ needs.
